Search Results - "NYGREN, Peter"

Refine Results
  1. 1

    Aminopeptidase N (CD13) as a target for cancer chemotherapy by Wickström, Malin, Larsson, Rolf, Nygren, Peter, Gullbo, Joachim

    Published in Cancer science (01-03-2011)
    “…The enzyme aminopeptidase N (APN, also known as CD13) is a Zn2+ dependent membrane‐bound ectopeptidase that degrades preferentially proteins and peptides with…”
    Get full text
    Journal Article
  2. 2

    Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system by Karlsson, Henning, Fryknäs, Mårten, Larsson, Rolf, Nygren, Peter

    Published in Experimental cell research (01-08-2012)
    “…Clinically relevant in vitro methods are needed to identify new cancer drugs for solid tumors. We report on a new 3-D spheroid cell culture system aimed to…”
    Get full text
    Journal Article
  3. 3

    The fluorometric microculture cytotoxicity assay by Lindhagen, Elin, Nygren, Peter, Larsson, Rolf

    Published in Nature protocols (01-08-2008)
    “…The fluorometric microculture cytotoxicity assay (FMCA) is a nonclonogenic microplate-based cell viability assay used for measurement of the cytotoxic and/or…”
    Get full text
    Journal Article
  4. 4

    Three-Dimensional Cell Culture-Based Screening Identifies the Anthelmintic Drug Nitazoxanide as a Candidate for Treatment of Colorectal Cancer by Senkowski, Wojciech, Zhang, Xiaonan, Olofsson, Maria Hägg, Isacson, Ruben, Höglund, Urban, Gustafsson, Mats, Nygren, Peter, Linder, Stig, Larsson, Rolf, Fryknäs, Mårten

    Published in Molecular cancer therapeutics (01-06-2015)
    “…Because dormant cancer cells in hypoxic and nutrient-deprived regions of solid tumors provide a major obstacle to treatment, compounds targeting those cells…”
    Get full text
    Journal Article
  5. 5

    Phenotypic screening platform identifies statins as enhancers of immune cell-induced cancer cell death by Selvin, Tove, Berglund, Malin, Lenhammar, Lena, Jarvius, Malin, Nygren, Peter, Fryknäs, Mårten, Larsson, Rolf, Andersson, Claes R

    Published in BMC cancer (17-02-2023)
    “…High-throughput screening (HTS) of small molecule drug libraries has greatly facilitated the discovery of new cancer drugs. However, most phenotypic screening…”
    Get full text
    Journal Article
  6. 6

    Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data by von Heideman, Anne, Berglund, Åke, Larsson, Rolf, Nygren, Peter

    Published in Cancer chemotherapy and pharmacology (01-05-2010)
    “…Purpose Depletion of cellular nicotinamide adenine dinucleotide (NAD) by inhibition of its synthesis is a new pharmacological principle for cancer treatment…”
    Get full text
    Journal Article
  7. 7

    Sorafenib and nitazoxanide disrupt mitochondrial function and inhibit regrowth capacity in three-dimensional models of hepatocellular and colorectal carcinoma by Ek, Frida, Blom, Kristin, Selvin, Tove, Rudfeldt, Jakob, Andersson, Claes, Senkowski, Wojciech, Brechot, Christian, Nygren, Peter, Larsson, Rolf, Jarvius, Malin, Fryknäs, Mårten

    Published in Scientific reports (27-05-2022)
    “…Quiescent cancer cells in malignant tumors can withstand cell-cycle active treatment and cause cancer spread and recurrence. Three-dimensional (3D) cancer cell…”
    Get full text
    Journal Article
  8. 8

    Large-Scale Gene Expression Profiling Platform for Identification of Context-Dependent Drug Responses in Multicellular Tumor Spheroids by Senkowski, Wojciech, Jarvius, Malin, Rubin, Jenny, Lengqvist, Johan, Gustafsson, Mats G, Nygren, Peter, Kultima, Kim, Larsson, Rolf, Fryknäs, Mårten

    Published in Cell chemical biology (17-11-2016)
    “…Cancer cell lines grown as two-dimensional (2D) cultures have been an essential model for studying cancer biology and anticancer drug discovery. However, 2D…”
    Get more information
    Journal Article
  9. 9

    Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy by Rendo, Veronica, Stoimenov, Ivaylo, Mateus, André, Sjöberg, Elin, Svensson, Richard, Gustavsson, Anna-Lena, Johansson, Lars, Ng, Adrian, OʼBrien, Casey, Giannakis, Marios, Artursson, Per, Nygren, Peter, Cheong, Ian, Sjöblom, Tobias

    Published in Nature communications (11-03-2020)
    “…Cancer chemotherapy targeting frequent loss of heterozygosity events is an attractive concept, since tumor cells may lack enzymatic activities present in…”
    Get full text
    Journal Article
  10. 10

    Novel activity of acriflavine against colorectal cancer tumor cells by Hassan, Saadia, Laryea, Daniel, Mahteme, Haile, Felth, Jenny, Fryknäs, Mårten, Fayad, Walid, Linder, Stig, Rickardson, Linda, Gullbo, Joachim, Graf, Wilhelm, Påhlman, Lars, Glimelius, Bengt, Larsson, Rolf, Nygren, Peter

    Published in Cancer science (01-12-2011)
    “…A high‐throughput screen of the cytotoxic activity of 2000 molecules from a commercial library in three human colon cancer cell lines and two normal cell types…”
    Get full text
    Journal Article
  11. 11

    Prognostic factors in patients with loco-regionally advanced gastric cancer by Hultman, Bo, Gunnarsson, Ulf, Nygren, Peter, Sundbom, Magnus, Glimelius, Bengt, Mahteme, Haile

    Published in World journal of surgical oncology (15-09-2017)
    “…The aim of this study was to investigate epidemiologic and prognostic factors relevant to the treatment of loco-regionally advanced gastric cancer (GC). Two…”
    Get full text
    Journal Article
  12. 12

    Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibition by Blom, Kristin, Rubin, Jenny, Berglund, Malin, Jarvius, Malin, Lenhammar, Lena, Parrow, Vendela, Andersson, Claes, Loskog, Angelica, Fryknäs, Mårten, Nygren, Peter, Larsson, Rolf

    Published in BMC research notes (22-04-2019)
    “…We recently showed that the anti-helminthic compound mebendazole (MBZ) has immunomodulating activity by inducing a M2 to M1 phenotype switch in…”
    Get full text
    Journal Article
  13. 13

    Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei by Bjersand, Kathrine, Mahteme, Haile, Sundström Poromaa, Inger, Andréasson, Håkan, Graf, Wilhelm, Larsson, Rolf, Nygren, Peter

    Published in Annals of surgical oncology (01-12-2015)
    “…Background Cytoreductive surgery (CRS) and intraperitoneal chemotherapy (IPC) is an established therapy for pseudomyxoma peritonei (PMP). However, the role of…”
    Get full text
    Journal Article
  14. 14

    Inhibition of proteasome activity, nuclear factor‐KB translocation and cell survival by the antialcoholism drug disulfiram by Lövborg, Henrik, Öberg, Fredrik, Rickardson, Linda, Gullbo, Joachim, Nygren, Peter, Larsson, Rolf

    Published in International journal of cancer (15-03-2006)
    “…The proteasome pathway is an important target for anticancer drug development. Here, we identify the antialcoholism drug disulfiram and its analogue…”
    Get full text
    Journal Article
  15. 15

    Multiparametric evaluation of apoptosis: Effects of standard cytotoxic agents and the cyanoguanidine CHS 828 by Lövborg, Henrik, Nygren, Peter, Larsson, Rolf

    Published in Molecular cancer therapeutics (01-05-2004)
    “…A multiparametric high-content screening assay for measurement of apoptosis was developed. HeLa cells and lymphoma U-937 cells were exposed to cytotoxic drugs…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients by NYGREN, Peter, HANDE, Kenneth, GOTTESDIENER, Keith M, COCQUYT, Veronique, VAN BELLE, Simon, PETTY, Kevin J, FEDGCHIN, Margaret, VAN DYCK, Kristien, MAJUMDAR, Anup, PANEBIANCO, Debbie, DE SMET, Marina, AHMED, Tuli, MURPHY, M. Gail

    Published in Cancer chemotherapy and pharmacology (01-06-2005)
    “…Aprepitant is a selective neurokinin-1 receptor antagonist that is effective for the prevention of nausea and vomiting caused by highly emetogenic…”
    Get full text
    Journal Article
  18. 18

    A systematic overview of chemotherapy effects in ovarian cancer by Högberg, T, Glimelius, B, Nygren, P

    Published in Acta oncologica (2001)
    “…A systematic review of chemotherapy trials in several tumour types was performed by The Swedish Council of Technology Assessment in Health Care (SBU). The…”
    Get more information
    Journal Article
  19. 19
  20. 20

    A systematic overview of chemotherapy effects in non-small cell lung cancer by Sörenson, S, Glimelius, B, Nygren, P

    Published in Acta oncologica (2001)
    “…A systematic review of chemotherapy trials in several tumour types was performed by The Swedish Council of Technology Assessment in Health Care (SBU). The…”
    Get more information
    Journal Article